Claes Bornaes

Title: Claes Bornaes: Innovator in Factor VII and VIIa-like Molecules

Introduction

Claes Bornaes is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of Factor VII and VIIa-like molecules. His work has implications for medical treatments and therapeutic applications.

Latest Patents

Claes Bornaes holds a patent for "Factor VII or VIIA-like molecules." This patent includes conjugates of Factor VII (FVII) and Factor VIIa (FVIIA), along with methods for preparing them. Additionally, he has developed methods for producing novel polypeptides that contribute to the production of such conjugates. His patent also outlines methods of treatment by administering a FVII or FVIIa conjugate.

Career Highlights

Claes Bornaes is currently employed at Bayer Healthcare LLC, where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative treatments.

Collaborations

Claes has collaborated with notable colleagues, including Anders Pedersen and Kim Vilbour Andersen. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Claes Bornaes is a distinguished inventor whose work on Factor VII and VIIa-like molecules has the potential to transform therapeutic approaches in medicine. His contributions to biotechnology are invaluable and continue to pave the way for future innovations.